Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1033 - 1040 of 11616 results
How Recent Canada Labour Code Updates Are Impacting Federally Regulated Employers
August 23, 2023| News
Protecting Victims’ Privacy in Sensitive Criminal Cases
August 23, 2023| Article| Viewpoint
Protecting Victims’ Privacy in Sensitive Criminal Cases
August 22, 2023| Article| Viewpoint
Considering Converting an LLC into a Corporation? Here Are the QSBS Issues You Should Be Thinking About
August 22, 2023| Alert| Viewpoint
Law360's 2023 Telecommunications Editorial Advisory Board
August 22, 2023| News
$4.3 Million Or $1.27 Million? What’s The Point Of Scary Retirement Projection Numbers?
August 22, 2023| News
What Is A Major Advantage Of Separately Managed Accounts (SMAs)?
August 22, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.